Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: IMIPRAMINE PAMOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc)

View source ↗

Summary

FDA approved a supplemental application for Imipramine Pamoate by Hikma Pharmaceuticals USA Inc, enabling a generic imipramine pamoate product to be marketed. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imipramine Pamoate (Imipramine pamoate)

Snippet

SUPPL AP for IMIPRAMINE PAMOATE (IMIPRAMINE PAMOATE)